FDA Inspection 1312222 — BioTissue Holdings Inc

BioTissue Holdings Inc — FEI 3009809074

The FDA completed an inspection of BioTissue Holdings Inc on Sep 1, 2026 in Doral, FL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Biologics.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Sep 1, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Doral, FL (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.